Vanderbilt-Ingram Cancer Center has received $2.3 million to fund a clinical research trial testing a combination of three immunotherapy compounds for patients with a specific type of advanced breast cancer.
https://news.vanderbilt.edu/2017/10/26/study-to-test-combination-therapy-for-breast-cancer/#new_tab
